Evidence map›Paper›PMID 34152814›Full record

ArticleAntimicrobial agents and chemotherapy2021

Properties of Plasmodium falciparum with a Deleted Apicoplast DNA Gyrase.

SooNee Tan, Devaraja G Mudeppa, Sreekanth Kokkonda, John White, Rapatbhorn Patrapuvich, Pradipsinh K Rathod

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Targeting theHeliyon · 2022
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

SooNee TanDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Devaraja G MudeppaDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Sreekanth KokkondaDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
John WhiteDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Rapatbhorn PatrapuvichDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Pradipsinh K RathodDepartment of Chemistry, University of Washingtongrid.34477.33, Seattle, Washington, USA.
University of Washington · USMahidol Oxford Tropical Medicine Research Unit · TH

Funding

Shared TechnologyU19AI089688 · NIAID · UNIVERSITY OF WASHINGTON · PI DURAISINGH, MANOJ T · 2010 to 2023
$22.4M
Malaria Topoisomerase inhibitorsR01AI093380 · NIAID · UNIVERSITY OF WASHINGTON · PI RATHOD, PRADIPSINH K. · 2011 to 2020
$3.4M
HHS | National Institutes of Health (NIH) R01 093380NIAID NIH HHS R01 AI093380NIAID NIH HHS U19 AI089688Wellcome Trust
6 · The paper itself

Abstract

Malaria parasites have three genomes: a nuclear genome, a mitochondrial genome, and an apicoplast genome. Since the apicoplast is a plastid organelle of prokaryotic origin and has no counterpart in the human host, it can be a source of novel targets for antimalarials. Plasmodium falciparum DNA gyrase (

Indexed as

AntimalarialsApicoplastsDNA GyraseHumansPlasmodium falciparumProtozoan ProteinsAntimalarialsDNA GyraseProtozoan ProteinsapicoplastciprofloxacinCRISPR/Cas9DNA gyrasePlasmodium falciparum

Identifiers

PMID34152814
PMCPMC8370227
OpenAlexW3176608394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.